- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07344155
SOAR: Surgery Objective Analysis and Review (SOAR)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Surgery Residents:
- General surgery trainee or attending surgeon at Johns Hopkins.
- Must be able to operate.
- 18 years or older
Patients:
- Undergoing laparoscopic surgery at Johns Hopkins
Exclusion Criteria:
- None for surgery residents
- Patients: cases without record of video
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SOAR Webapp
surgical residents through all years of training
|
Surgical residents will use the SOAR Webapp, a video-based surgical education platform, to review intracorporeal laparoscopic procedure recordings and receive structured feedback on technical skills and surgical decision-making.
The intervention includes post-operative video review with an expert surgeon and automated analytic outputs generated by computer vision algorithms, including performance metrics and annotated video segments.
The intervention is used for educational and training purposes only and does not alter patient care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived resident educational impact and accuracy of operative performance assessment as measured by the SOAR Post-Intervention Evaluation Survey
Time Frame: 2 years
|
This is a survey completed by surgical trainees following use of the SOAR Web Application. The survey evaluates trainee perceptions of:
All survey items are measured using a 3-point Likert scale (Never, Sometimes, Often), with higher scores indicating greater perceived frequency, accuracy, usefulness, or educational impact, depending on the item. Survey responses are analyzed at the individual item level and summarized as frequencies and proportions. The maximum score is 30, minimum 10. |
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeffrey K Jopling, MD, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00487162
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.